Mucinous Adenocarcinoma of the Ovary

被引：3

作者：

Sholi, Abdalla

Martino, Martin M.

Pirigyi, Megan

Rosenblum, Norman G.

Markman, Maurie

Peterson, Candace S.

Bradbury, Angela R. ^{[3
]}

Morris, Gloria J. ^{[1
,2
]}

机构：

[1] Hematol & Oncol Associates NE PA, PC, Dunmore, PA 18512 USA

[2] Commonwealth Med Coll, Scranton, PA USA

[3] Fox Chase Canc Ctr, Dept Clin Genet, Philadelphia, PA 19111 USA

来源：

SEMINARS IN ONCOLOGY | 2010年 / 37卷 / 04期

关键词：

PHASE-III TRIAL; INTRAPERITONEAL CHEMOTHERAPY; CANCER; PACLITAXEL; 5-FLUOROURACIL; OXALIPLATIN; CARBOPLATIN; CARCINOMA; CISPLATIN; MUTATIONS;

D O I：

10.1053/j.seminoncol.2010.06.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：314 / 320

页数：7

共 25 条

[1]

[Anonymous], 2009, CANC FACTS FIG 2009

[2] Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].

Armstrong, DK ;

Bundy, B ;

Wenzel, L ;

Huang, HQ ;

Baergen, R ;

Lele, S ;

Copeland, LJ ;

Walker, JL ;

Burger, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43

[3] Mucinous But Not Clear Cell Histology Is Associated With Inferior Survival in Patients With Advanced Stage Ovarian Carcinoma Treated With Platinum-Paclitaxel Chemotherapy [J].

Bamias, Aristotle ;

Psaltopoulou, Theodora ;

Sotiropoulou, Maria ;

Haidopoulos, Dimitrios ;

Lianos, Evangelos ;

Bournakis, Evangelos ;

Papadimitriou, Christos ;

Rodolakis, Alexandros ;

Vlahos, George ;

Dimopoulos, Meletius A. .

CANCER, 2010, 116 (06) :1462-1468

[4] Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study [J].

Bell, Jeffrey ;

Brady, Mark F. ;

Young, Robert C. ;

Lage, Janice ;

Walker, Joan L. ;

Look, Katherine Y. ;

Rose, G. Scott ;

Spirtos, Nick M. .

GYNECOLOGIC ONCOLOGY, 2006, 102 (03) :432-439

[5] The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study [J].

Chan, John K. ;

Tian, Chunqiao ;

Fleming, Gini F. ;

Monk, Bradley J. ;

Herzog, Thomas J. ;

Kapp, Daniel S. ;

Bell, Jeffrey .

GYNECOLOGIC ONCOLOGY, 2010, 116 (03) :301-306

[6]

COTRAN RS, 1994, MUCINOUS CYSTADENOCA, P1065

[7] Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers. [J].

Fong, Peter C. ;

Boss, David S. ;

Yap, Timothy A. ;

Tutt, Andrew ;

Wu, Peijun ;

Mergui-Roelvink, Marja ;

Mortimer, Peter ;

Swaisland, Helen ;

Lau, Alan ;

O'Connor, Mark J. ;

Ashworth, Alan ;

Carmichael, James ;

Kaye, Stan B. ;

Schellens, Jan H. M. ;

de Bono, Johann S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :123-134

[8] Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2:: Analysis of 10,000 individuals [J].

Frank, TS ;

Deffenbaugh, AM ;

Reid, JE ;

Hulick, M ;

Ward, BE ;

Lingenfelter, B ;

Gumpper, KL ;

Scholl, T ;

Tavtigian, SV ;

Pruss, DR ;

Critchfield, GC .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1480-1490

[9] Mucinous epithelial ovarian cancer: A separate entity requiring specific treatment [J].

Hess, V ;

A'Hern, R ;

Nasiri, N ;

King, DM ;

Blake, PR ;

Barton, DPJ ;

Shepherd, JH ;

Ind, T ;

Bridges, J ;

Harrington, K ;

Kaye, SB ;

Gore, ME .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1040-1044

[10] Pathology of ovarian cancers in BRCA1 and BRCA2 carriers [J].

Lakhani, SR ;

Manek, S ;

Penault-Llorca, F ;

Flanagan, A ;

Arnout, L ;

Merrett, S ;

McGuffog, L ;

Steele, D ;

Devilee, P ;

Klijn, JGM ;

Meijers-Heijboer, H ;

Radice, P ;

Pilotti, S ;

Nevanlinna, H ;

Butzow, R ;

Sobol, H ;

Jacquemier, J ;

Lyonet, DS ;

Neuhausen, SL ;

Weber, B ;

Wagner, T ;

Winqvist, R ;

Bignon, YJ ;

Monti, F ;

Schmitt, F ;

Lenoir, G ;

Seitz, S ;

Hamman, U ;

Pharoah, P ;

Lane, G ;

Ponder, B ;

Bishop, DT ;

Easton, DF .

CLINICAL CANCER RESEARCH, 2004, 10 (07) :2473-2481

← 1 2 3 →